Table 2 Respondents’ characteristics and distributions of item responses

Age

12–54 years

161 (47.8%)

55 years and above

176 (52.2%)

Gender

Female

228 (68.1%)

Male

107 (31.9%)

Race

White

295 (88.6%)

Other

38 (11.4%)

Ethnicity

Hispanic or Latino/a

9 (3.1%)

Not Hispanic or Latino/a

281 (96.9%)

Marital status

Married

207 (62.4%)

Other

125 (37.7%)

Employment status

Employed full time or part time

179 (56.1%)

Other

140 (43.9%)

Household income

Less than $50,000

116 (38.9%)

$50,000 or more

182 (61.1%)

Survey Items

Agree

Disagree

OUD as disease

254 (76.5%)

78 (23.5%)

Addiction to pain medications

322 (96.1%)

13 (3.9%)

Can stop drug use

145 (44.8%)

179 (55.2%)

Possible to recover

309 (95.1%)

16 (4.9%)

Higher rate of SUD-affected newborn

169 (58.7%)

119 (41.3%)

Adequate resources for pregnant women with SUD

103 (35.0%)

191 (64.9%)

Abstinence based therapy only

93 (30.7%)

210 (69.3%)

Relapse of overdose

35 (11.2%)

278 (88.8%)

Willingness to live in neighborhood of OUD

153 (49.8%)

154 (50.2%)

OUD only for low-income individuals

24 (7.3%)

304 (92.7%)

Easily spotting OUD

76 (23.7%)

245 (76.3%)

Embarrassed to reveal individuals with OUD

88 (27.2%)

236 (72.8%)

OUD dangerous

133 (42.6%)

179 (57.4%)

Same right to a job

170 (54.8%)

140 (45.2%)

OUD part of supportive community

302 (94.1%)

19 (5.9%)

Comprehensive prenatal care to pregnant women with SUD

303 (95.3%)

15 (4.7%)

Naloxone administration to a stranger

226 (71.5%)

90 (28.5%)

Every time naloxone administration to overdose

188 (62.1%)

115 (37.9%)

Country at risk for HIV or HCV outbreak

154 (54.2%)

130 (45.8%)

Effectiveness of MOUD

195 (69.9%)

84 (30.1%)

True

False

HCV screening offered

115 (36.9%)

197 (63.2%)

HIV screening offered

97 (31.2%)

214 (68.8%)